- Home
- NRXP vs SST Comparison
NRXP vs SST Comparison
Compare NRXP & SST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NRXP | SST |
|---|---|---|
| Founded | 2015 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.5M | 67.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NRXP | SST |
|---|---|---|
| Price | $2.37 | $4.17 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | ★ $30.50 | $10.00 |
| AVG Volume (30 Days) | ★ 430.4K | 27.7K |
| Earning Date | 11-17-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $242,000.00 | ★ $289,784,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $643.59 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.15 | $2.90 |
| 52 Week High | $6.01 | $15.00 |
Technical Indicators
Market Signals| Indicator | NRXP | SST |
|---|---|---|
| Relative Strength Index (RSI) | 45.73 | 47.75 |
| Support Level | $2.22 | $3.54 |
| Resistance Level | $2.51 | $5.25 |
| Average True Range (ATR) | 0.16 | 0.42 |
| MACD | 0.03 | 0.19 |
| Stochastic Oscillator | 66.67 | 53.92 |
Price Performance
Historical ComparisonAbout NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
About SST System1 Inc.
System1 Inc develops technology and data science to operate a responsive acquisition marketing platform. It serves customers in the areas of health and wellness, automotive, finance, travel, and entertainment. The company's segment includes Owned and Operated Advertising (O&O); and Partner Network. It generates maximum revenue from the Owned and Operated Advertising (O&O) segment. Geographically, it operates in United States and Other countries.